Other and unspecified nerve root and plexus disorders, also in other diseases

G6_ROOTPLEXOTHUNS

peripheral nervous system disease: A disease involving the peripheral nervous system.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G54.8, G54.9, G55* Hospital discharge: ICD-9 — 353[8-9] Cause of death: ICD-10 — G54.8, G54.9, G55* Cause of death: ICD-9 — 353[8-9] 2 out of 7 registries used, show all original rules.	8320
4. Check minimum number of events None	8320
5. Include endpoints None	8320
6. Filter based on genotype QC (FinnGen only)	8320

Control definitions (FinnGen only)

Control exclude: G6_NERPLEX

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	G6_ROOTPLEXOTHUNS
CONTROL_EXCLUDE	G6_NERPLEX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G54[8-9]\|G55
HD_ICD_9	353[8-9]
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G54[8-9]\|G55
COD_ICD_9	353[8-9]
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified nerve root and plexus disorders, also in other diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	45171	22065	22893
Only index persons	43174	21254	21920
Unadjusted period prevalence (%)
Whole population	0.63	0.63	0.64
Only index persons	0.81	0.78	0.84
Median age at first event (years)
Whole population	52.39	53.19	51.68
Only index persons	51.98	52.71	51.27

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8320	4573	3747
Unadjusted period prevalence (%)	1.60	1.56	1.65
Median age at first event (years)	54.09	52.90	55.55

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7287: Matched controls
72869

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.6

323.3

1753

5929

M03BX02

ATC

tizanidine; oral

3.1

323.0

5426

35506

N06AX21

ATC

duloxetine; oral

4.8

323.0

1442

3539

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.8

323.0

4134

23153

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

9.2

323.0

783

936

G56.0

ICD-10 Finland

Carpal tunnel syndrome

19.8

323.0

1240

746

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

6.9

323.0

1041

1729

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

6.3

323.0

1577

3039

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

11.0

323.0

684

678

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

7.5

323.0

1496

2417

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

436.5

323.0

1772

L03

ICPC

Low back symptom/complaint

3.9

323.0

2713

9642

ACC51

NOMESCO Finland

Release of median nerve

119.7

323.0

584

N03AX16

ATC

pregabalin; oral

7.3

323.0

3634

8708

M48.0

ICD-10 Finland

Spinal stenosis

8.1

323.0

2019

3283

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

15.9

323.0

695

480

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

10.8

323.0

2244

2877

G55.2

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

168.3

323.0

574

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

580.2

323.0

3609

123

M47.9

ICD-10 Finland

Spondylosis, unspecified

15.9

323.0

820

576

WX704

NOMESCO Finland

Intubation

5.7

323.0

1165

2360

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

14.4

323.0

654

496

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

8.1

323.0

914

1272

M54.5

ICD-10 Finland

Low back pain

3.6

323.0

3469

14692

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

21.1

323.0

1501

886

G54.9

ICD-10 Finland

Nerve root and plexus disorder, unspecified

205.4

323.0

352

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

6.6

323.0

1525

2824

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

731.4

323.0

901

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

54.2

323.0

410

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

14.0

323.0

3705

5023

M54.4

ICD-10 Finland

Lumbago with sciatica

6.8

323.0

2776

6052

M01AH05

ATC

etoricoxib; oral

2.7

323.0

5049

33006

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

10.6

323.0

1102

1203

L86

ICPC

Back syndrome with radiating pain

8.2

323.0

1020

1412

N02AJ06

ATC

codeine and paracetamol; systemic

3.1

323.0

3620

17773

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

149.1

323.0

1026

N03AX12

ATC

gabapentin; oral

10.0

323.0

3065

4922

N02AX02

ATC

tramadol; systemic, rectal

4.3

323.0

4480

19774

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

8.9

323.0

927

1179

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

51.9

317.2

384

N02BE01

ATC

paracetamol; systemic, rectal

3.5

295.1

6547

52090

M54.1

ICD-10 Finland

Radiculopathy

8.2

291.2

692

925

M54.3

ICD-10 Finland

Sciatica

5.5

269.2

860

1717

G54.0

ICD-10 Finland

Brachial plexus disorders

32.5

268.6

359

116

M03BC01

ATC

orphenadrine (citrate); systemic

2.7

266.5

2319

10648

XA402

NOMESCO Finland

ENMG

12.3

250.7

471

407

WX408

NOMESCO Finland

General anesthesy, balanced

2.5

228.1

2400

12046

N06AA09

ATC

amitriptyline; systemic

3.8

226.8

1066

3113

M01AB05

ATC

diclofenac; systemic, rectal

2.3

222.6

5251

38567

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.5

219.9

1169

3771

WX725

NOMESCO Finland

Noninvasive ventilation

5.6

218.2

687

1335

G56.2

ICD-10 Finland

Lesion of ulnar nerve

24.1

210.5

305

132

TPH04

NOMESCO Finland

Cathetrisation of vein

2.6

208.0

1835

8278

M79.6

ICD-10 Finland

Pain in limb

2.3

207.3

2797

15721

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.4

206.1

2309

11840

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

14.4

203.1

354

257

Z01.8

ICD-10 Finland

Other specified special examinations

2.6

203.0

1884

8727

G54.8

ICD-10 Finland

Other nerve root and plexus disorders

230.7

196.5

202

SPAT1153

SPAT

Removal of sutures

2.2

189.1

2511

13854

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

6.6

188.9

514

825

A02BC02

ATC

pantoprazole; systemic

2.1

184.9

4809

35173

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.3

184.7

1076

3683

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

6.0

182.6

537

954

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.4

181.1

1953

9698

WX720

NOMESCO Finland

Own respiration

5.6

180.7

561

1065

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

7.7

167.2

408

558

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

8.4

167.0

384

478

SPAT1263

SPAT

Sampling

2.0

166.9

3203

20385

A02BC03

ATC

lansoprazole; oral

2.2

165.8

2303

12793

M50.3

ICD-10 Finland

Other cervical disc degeneration

8.1

162.4

381

490

N02AA05

ATC

oxycodone; systemic

2.8

156.4

1158

4614

N06AX16

ATC

venlafaxine; oral

2.7

153.8

1249

5258

A02BC05

ATC

esomeprazole; systemic

2.0

149.7

3069

19766

M01AE03

ATC

ketoprofen; systemic, rectal

2.0

144.6

2846

17978

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

13.8

143.1

253

189

M54.2

ICD-10 Finland

Cervicalgia

3.5

142.7

724

2205

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

6.5

142.1

388

622

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

21.1

141.4

213

104

M43.1

ICD-10 Finland

Spondylolisthesis

5.0

141.3

484

1022

M47.82

ICD-10 Finland

Other spondylosis, cervical region

5.1

138.0

464

959

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

7.8

136.4

328

437

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.5

134.2

688

2109

SPAT1301

SPAT

No procedures

2.0

132.9

2284

13584

Z50.1

ICD-10 Finland

Other physical therapy

4.0

131.7

576

1545

R51.80

ICD-10 Finland

Headache

2.5

131.6

1201

5353

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.7

131.5

623

1790

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

14.2

126.7

221

160

WX402

NOMESCO Finland

General anaesthesia

2.3

126.3

1418

6999

M01AE01

ATC

ibuprofen; systemic, rectal

2.4

125.0

6616

58405

M19.0

ICD-10 Finland

Primary arthrosis of other joints

3.0

125.0

810

2933

M01AC06

ATC

meloxicam; systemic, rectal

1.9

124.6

2735

17698

M01AH01

ATC

celecoxib; oral (coxibs)

2.3

124.1

1425

7103

AA1AD

NOMESCO Finland

CT of head and brain

2.1

122.2

1677

9047

WX702

NOMESCO Finland

Supraglottic ventilation device

3.7

121.9

583

1685

H02AB06

ATC

prednisolone; systemic

1.8

121.8

3289

22779

S18

ICPC

Laceration/cut

1.8

120.4

2892

19235

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

24.2

120.2

173

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

120.1

2532

16096

M25.5

ICD-10 Finland

Pain in joint

2.0

118.2

2094

12476

N06AX11

ATC

mirtazapine; oral

1.9

118.0

2355

14660

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

116.1

2989

20273

L01

ICPC

Neck symptom/complaint

2.4

108.7

1068

4900

WX110

NOMESCO Finland

Local anesthesy

1.7

105.9

4905

39396

M01AH02

ATC

rofecoxib; oral

2.4

105.4

998

4489

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

103.7

1879

11188

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

8.5

102.6

233

283

XX2CT

NOMESCO Finland

Other injection with CT guidance

38.1

102.3

131

M70.6

ICD-10 Finland

Trochanteric bursitis

2.5

102.2

900

3890

R03AC02

ATC

salbutamol; inhalant

1.7

100.6

3665

27217

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

96.9

3963

30277

A02BC01

ATC

omeprazole; systemic

1.9

96.6

1910

11677

M01AE02

ATC

naproxen; oral, rectal

1.7

96.2

3985

30527

L17

ICPC

Foot/toe symptom/complaint

1.9

93.4

1699

10066

M03BC51

ATC

orphenadrine, combinations; systemic

1.8

93.3

2096

13344

A01

ICPC

Pain general/multiple sites

2.9

91.6

605

2199

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

22.2

91.5

135

R52.2

ICD-10 Finland

Other chronic pain

4.7

91.2

326

716

J01AA02

ATC

doxycycline; systemic

1.7

90.1

5504

46621

L13

ICPC

Hip symptom/complaint

2.2

88.9

1086

5478

TPH07

NOMESCO Finland

Cathetrisation of artery

2.5

88.6

788

3409

ACC53

NOMESCO Finland

Release of ulnar nerve

73.3

88.5

101

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

8.5

88.3

200

242

M01AX17

ATC

nimesulide; oral

1.9

88.1

1696

10217

J01DB01

ATC

cefalexin; oral

1.8

87.8

5781

49836

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

87.8

4982

41106

N03AE01

ATC

clonazepam; systemic

3.2

87.6

506

1679

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

16.8

87.5

142

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

87.1

3460

25900

Z01.9

ICD-10 Finland

Special examination, unspecified

3.2

86.5

497

1642

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

4.5

86.4

323

742

N05CF01

ATC

zopiclone; oral

1.7

84.8

2138

14027

G44.2

ICD-10 Finland

Tension-type headache

2.2

84.6

975

4787

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

12.9

84.5

153

121

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

84.4

1115

5808

SPAT1097

SPAT

Recording of ECG

2.1

80.9

1046

5393

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

80.2

2789

19985

L08

ICPC

Shoulder symptom/complaint

1.9

79.1

1303

7385

A02BA02

ATC

ranitidine; systemic

1.9

79.1

1328

7580

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.9

79.1

1349

7746

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.9

77.9

500

1778

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

77.6

2781

20033

SPAT1310

SPAT

Counselling related to known health issue

1.7

76.5

2138

14368

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.9

75.6

258

539

L12

ICPC

Hand/finger symptom/complaint

2.1

75.2

956

4882

G56.4

ICD-10 Finland

Causalgia

134.8

75.0

J01MA02

ATC

ciprofloxacin; systemic

1.6

74.4

2585

18414

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

74.4

1465

8821

SPAT1260

SPAT

Consultation of another employee

1.9

74.3

1233

6987

M79.1

ICD-10 Finland

Myalgia

2.1

74.3

918

4629

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.5

74.2

624

2610

R20.2

ICD-10 Finland

Paraesthesia of skin

2.8

73.7

523

1981

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

72.9

1213

6877

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.3

71.8

736

3405

NA3BG

SPAT

4.8

71.8

250

534

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

71.7

780

3710

A06AD11

ATC

lactulose; oral

2.1

71.6

871

4356

R06.0

ICD-10 Finland

Dyspnoea

1.8

71.5

1560

9692

R52.1

ICD-10 Finland

Chronic intractable pain

10.7

71.3

141

134

M02AA07

ATC

piroxicam; topical

1.6

70.9

2395

16874

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

70.9

873

4388

G54.4

ICD-10 Finland

Lumbosacral root disorders, not elsewhere classified

109.7

70.0

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

12.5

69.4

127

103

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.8

69.1

306

822

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

69.0

4412

36242

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

68.4

1847

12211

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.7

68.3

1902

12685

G551, M501

ICD-10 Finland

+∞

67.8

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

67.4

1989

13470

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.7

67.0

509

2006

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

5.1

66.8

219

438

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.0

66.5

1017

5569

J01FF01

ATC

clindamycin; systemic

1.7

66.3

1832

12170

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

66.0

2606

19018

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

21.8

65.7

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.2

65.7

777

3829

G51.0

ICD-10 Finland

Bell palsy

20.5

65.7

N06AA10

ATC

nortriptyline; systemic

4.9

65.3

224

471

G552, M501

ICD-10 Finland

+∞

64.7

J01DA01

ATC

[U] cefalexin; systemic

1.5

64.4

4265

35024

L84

ICPC

Back syndrome without radiat pain

3.2

64.3

362

1175

M54

ICD-10 Finland

Dorsalgia

2.1

63.9

820

4183

L28

ICPC

Limited function/disability (L)

2.0

63.8

916

4889

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

6.3

63.2

175

285

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

63.2

3613

28645

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.9

63.1

270

704

N03AX09

ATC

lamotrigine; oral

2.9

62.7

400

1415

R42

ICD-10 Finland

Dizziness and giddiness

1.8

62.5

1325

8110

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

5.3

62.4

198

382

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

62.3

1082

6194

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

61.3

1240

7470

SPAT1262

SPAT

Handing over of treatment supplies

1.8

61.1

1176

6972

J01FA10

ATC

azithromycin; systemic

1.5

60.6

3932

31929

M43.0

ICD-10 Finland

Spondylolysis

5.0

60.5

201

408

M01AH03

ATC

valdecoxib; oral

2.5

60.3

513

2152

R01AD09

ATC

mometasone; nasal

1.5

59.9

3044

23399

G83.4

ICD-10 Finland

Cauda equina syndrome

17.5

59.8

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

59.6

3422

27015

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.5

59.4

513

2167

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

59.0

1115

6558

M79.7

ICD-10 Finland

Fibromyalgia

3.6

58.9

279

793

P01AB01

ATC

metronidazole; oral, rectal

1.5

58.9

2628

19593

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

58.3

1526

9926

WX400

NOMESCO Finland

Inhalation anesthesy

2.9

58.1

379

1359

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.0

57.5

814

4311

N02AC04

ATC

dextropropoxyphene; oral

3.7

56.9

265

743

WX290

NOMESCO Finland

Other blockade of nerve

1.5

56.7

3003

23201

R09

ICPC

Sinus symptom/complaint

2.3

56.1

551

2485

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.1

55.8

687

3432

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

55.7

3949

32406

M54.6

ICD-10 Finland

Pain in thoracic spine

2.4

55.7

493

2110

9211

FHL

Exploration or removal of diskusprolapse

4.3

55.0

212

502

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.4

54.7

495

2143

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.2

54.6

597

2831

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

14.8

54.3

M01AX01

ATC

nabumetone; oral

3.0

54.3

340

1186

M77.1

ICD-10 Finland

Lateral epicondylitis

2.3

54.1

539

2444

UJF32

NOMESCO Finland

Coloscopy

1.6

53.7

1608

10815

L15

ICPC

Knee symptom/complaint

1.7

53.6

1277

8058

J01FA09

ATC

clarithromycin; systemic

1.5

53.1

2137

15462

G57.6

ICD-10 Finland

Lesion of plantar nerve

7.2

52.9

132

187

L02

ICPC

Back symptom/complaint

2.2

52.7

607

2945

TAB20

NOMESCO Finland

Epidural puncture

8.2

51.9

119

148

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.4

51.8

479

2094

R02

ICPC

Shortness of breath/dyspnoea

2.0

51.1

746

3989

UKC02

NOMESCO Finland

Cystoscopy

1.8

50.6

959

5624

J01CA04

ATC

amoxicillin; systemic

1.5

50.6

5500

48815

KMAK

NOMESCO Finland

1.5

50.5

3560

28921

R52.9

ICD-10 Finland

Pain, unspecified

2.2

50.4

556

2644

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.5

50.4

415

1708

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

50.3

1389

9118

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.1

50.3

651

3315

N05AH04

ATC

quetiapine; oral

1.8

50.2

1071

6524

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

50.0

576

2793

NF1AA

NOMESCO Finland

Hip X-ray examination

2.2

49.0

527

2475

M03BX01

ATC

baclofen; systemic

4.8

49.0

168

354

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

4.0

48.6

202

514

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.6

48.6

1377

9092

G47.3

ICD-10 Finland

Sleep apnoea

1.6

48.3

1432

9564

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

14.2

48.3

G99.2

ICD-10 Finland

Myelopathy in diseases classified elsewhere

18.5

48.3

M01AB55

ATC

diclofenac, combinations; oral

2.4

48.1

446

1949

N01

ICPC

Headache

2.1

48.0

613

3106

3540A

ICD-9 Finland

Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome

+∞

48.0

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

9.1

47.7

102

113

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.1

47.6

610

3090

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

6.0

47.6

136

232

UDC00

NOMESCO Finland

Ear microscopy

2.3

47.2

478

2183

SPAT1254

SPAT

Administration of medicine

1.8

47.1

842

4834

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.1

47.1

549

2673

G99.2*M47.9

ICD-10 Finland

Myelopathy in spondylosis

19.9

46.9

G551M

ICD-10 Finland

+∞

46.9

M01AX05

ATC

glucosamine; oral

1.7

46.8

1142

7223

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

46.6

1796

12782

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

46.5

1842

13191

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

46.4

1637

11408

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

46.3

2067

15205

R96

ICPC

Asthma

2.1

46.2

557

2752

J01EA01

ATC

trimethoprim; systemic

1.6

46.2

1480

10072

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.4

46.0

402

1707

NA3CM

NOMESCO Finland

Lumbar spine extensive MRI examination with 3 Tesla magnet

16.1

46.0

G99.2*M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

17.1

45.8

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

45.8

685

3689

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.9

45.3

767

4318

K02.1

ICD-10 Finland

Caries of dentine

1.4

44.9

3786

31523

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.1

44.6

547

2720

J02AC01

ATC

fluconazole; systemic

1.4

44.5

2563

19838

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.4

44.2

410

1792

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.3

44.1

420

1859

R05

ICPC

Cough

1.6

44.1

1377

9294

D07AC01

ATC

betamethasone; topical

1.5

43.9

2166

16231

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

3.2

43.6

239

762

ACC19

NOMESCO Finland

Transcision of peripheral nerve: other or unspecified

28.3

43.4

R07.3

ICD-10 Finland

Other chest pain

2.0

43.0

582

3013

WZA90

NOMESCO Finland

Other doctors statement

1.6

43.0

1447

9944

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

42.8

652

3529

N02AJ13

ATC

tramadol and paracetamol; systemic

3.9

42.5

182

476

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

42.3

3392

27852

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.9

42.3

263

914

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

42.3

1718

12326

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

42.1

472

2256

L14

ICPC

Leg/thigh symptom/complaint

2.2

41.8

455

2146

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

41.6

1145

7464

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

41.3

619

3333

K30

ICD-10 Finland

Functional dyspepsia

1.9

41.1

670

3718

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

14.8

41.0

G50.0

ICD-10 Finland

Trigeminal neuralgia

11.1

40.7

SPAT1058

SPAT

PEF monitoring instruction

2.0

40.6

528

2688

XF402

NOMESCO Finland

ECG with work load test

1.9

40.5

686

3854

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.3

40.5

380

1670

Z01.2

ICD-10 Finland

Dental examination

1.4

40.4

2602

20463

NF1DA

NOMESCO Finland

X-ray of hips

3.8

40.3

179

484

D01

ICPC

Abdominal pain/cramps general

1.9

40.1

636

3491

SPAT1240

SPAT

Therapeutic discussion

1.9

40.0

687

3878

C07AB07

ATC

bisoprolol; oral

1.4

40.0

2726

21656

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

40.0

794

4703

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

39.9

1146

7549

N06AB04

ATC

citalopram; systemic

1.6

39.9

1344

9213

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

8.1

39.9

113

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

39.9

503

2527

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.0

39.9

518

2635

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

39.8

2879

23113

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.8

39.8

777

4578

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.2

39.6

415

1923

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.0

39.3

547

2860

SPAT1081

SPAT

Cardiorespiratory global assessment

2.4

39.2

360

1566

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

39.1

759

4463

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

39.1

1202

8052

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

39.1

814

4893

HAMTE

NOMESCO Finland

6.6

39.0

103

159

G50.1

ICD-10 Finland

Atypical facial pain

7.8

38.9

118

G54.2

ICD-10 Finland

Cervical root disorders, not elsewhere classified

86.6

38.8

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

10.8

38.6

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.0

38.3

232

792

SGA01

NOMESCO Finland

Tooth opening as first aid

1.6

38.2

1048

6812

L09

ICPC

Arm symptom/complaint

2.6

38.2

284

1101

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

5.3

38.0

119

228

N06AB10

ATC

escitalopram; oral

1.6

37.9

1262

8615

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

37.6

764

4553

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

37.6

2671

21307

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.5

37.6

301

1217

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

6.3

37.4

101

161

N04BC05

ATC

pramipexole; oral

2.1

37.4

445

2182

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

4.0

37.3

155

396

AEA24

NOMESCO Finland

Removal of spinal stimulation elecrode

15.8

37.2

ZXA00

NOMESCO Finland

Right side

1.5

37.1

1530

10963

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.1

37.1

216

719

ABC66

NOMESCO Finland

Decompression of lumbal spinal channel

11.4

37.1

A01AB09

ATC

miconazole; local oral

2.0

36.9

517

2709

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.6

36.7

283

1122

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

36.6

838

5175

M53.2

ICD-10 Finland

Spinal instabilities

6.3

36.5

159

R75

ICPC

Sinusitis acute/chronic

2.5

36.5

310

1295

XKC03

NOMESCO Finland

Water cystometry

2.9

36.5

228

796

X58

ICD-10 Finland

Exposure to other specified factors

1.7

36.4

850

5279

N05BA01

ATC

diazepam; systemic, rectal

1.7

36.4

825

5079

N05BA04

ATC

oxazepam; oral

1.5

36.3

1478

10553

M76.0

ICD-10 Finland

Gluteal tendinitis

4.0

36.3

151

386

OAA65

SPAT

1.8

36.3

654

3750

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.0

36.2

216

731

G04CA02

ATC

tamsulosin; oral

1.6

36.0

1167

7907

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.8

35.9

618

3485

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

9.3

35.8

L29

ICPC

Musculoskeletal sympt/complt other

2.0

35.7

459

2324

J01FA06

ATC

roxithromycin; oral

1.4

35.6

2534

20161

C10AA07

ATC

rosuvastatin; oral

1.5

35.5

1437

10242

R06AE07

ATC

cetirizine; oral

1.4

35.5

2712

21847

L83

ICPC

Neck syndrome

6.9

35.4

132

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

3.5

35.4

171

496

D02

ICPC

Abdominal pain epigastric

2.2

35.2

366

1691

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.2

35.1

194

623

C08CA01

ATC

amlodipine; oral

1.4

35.1

1997

15248

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.7

35.1

721

4309

M65.3

ICD-10 Finland

Trigger finger

2.7

35.1

248

936

B01AB05

ATC

enoxaparin; parenteral

1.4

35.0

1790

13383

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

5.1

34.9

113

225

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

34.8

408

1985

C10AA05

ATC

atorvastatin; oral

1.4

34.8

2185

16985

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.2

34.5

387

1847

NAG41

NOMESCO Finland

Anterior fusion of cervical spine with fixation

8.5

34.4

ZXA05

NOMESCO Finland

Left side

1.5

34.4

1421

10164

C03CA01

ATC

furosemide; systemic

1.5

34.4

1348

9530

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

34.3

1012

6690

R03DC03

ATC

montelukast; oral

1.6

34.2

977

6404

Z71.9

ICD-10 Finland

Counselling, unspecified

2.2

34.2

369

1734

M89.0

ICD-10 Finland

Algoneurodystrophy

6.9

34.1

125

N07BC02

ATC

methadone; systemic

14.2

34.1

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

12.2

34.1

ABC20

NOMESCO Finland

Open discectomy of cervical spine

65.3

34.0

R03BA05

ATC

fluticasone; inhalant

1.6

33.8

1092

7377

RF210

NOMESCO Finland

2.9

33.8

209

726

G57.1

ICD-10 Finland

Meralgia paraesthetica

5.7

33.7

176

N03AF01

ATC

carbamazepine; oral, rectal

2.4

33.6

306

1323

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.9

33.6

543

2999

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

33.5

1225

8520

M01AC01

ATC

piroxicam; systemic, rectal

1.7

33.2

831

5254

SPAT1285

SPAT

Provision of consultation response

2.2

33.2

346

1598

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

33.1

405

2009

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.5

32.9

269

1103

D06

ICPC

Abdominal pain localized other

1.9

32.8

476

2525

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.4

32.7

293

1260

N05CF02

ATC

zolpidem; oral

1.5

32.6

1108

7574

XG410

NOMESCO Finland

Flow-volume spirometry

2.5

32.6

273

1133

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.3

32.5

326

1478

G56.3

ICD-10 Finland

Lesion of radial nerve

15.1

32.5

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

7.7

32.5

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4817

31063

2.31

292.80

4.7

3.9

—

(3047181) Lactate [Moles/volume] in Blood

771

1906

4.36

282.60

5.7

6.4

mmol/l

1.2

1.3

0.95

679

1677

(3032080) INR in Blood by Coagulation assay

4087

25507

2.18

257.40

7.9

8.3

inr

1.2

1.22

965

7519

(3039000) Anion gap in Blood

589

1366

4.56

233.34

6.2

7.5

mmol/l

10.9

11.3

1.74

530

1227

(3018572) Chloride [Moles/volume] in Blood

589

1367

4.56

233.12

6.2

7.5

mmol/l

105.0

105.2

0.23

530

1228

(3013826) Glucose [Moles/volume] in Serum or Plasma

5366

38266

2.13

226.84

5.3

4.6

mmol/l

6.6

2.41

5000

35739

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3310

20383

2.04

201.40

2.8

2.5

u/l

57.3

58.6

0.50

3094

18837

(3013707) Erythrocyte sedimentation rate by Westergren method

6388

49768

2.22

200.72

5.1

3.8

mm/h

11.0

11.4

1.62

6025

46274

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

764

2430

3.36

192.38

5.6

5.5

1.8

1.7

2.91

704

2274

(3007930) Methemoglobin/Hemoglobin.total in Blood

756

2400

3.36

190.90

5.7

5.5

1.0

0.9

5.57

696

2250

(3024561) Albumin [Mass/volume] in Serum or Plasma

4077

27761

1.92

178.40

4.9

g/l

36.2

35.8

4.35

3780

25866

(3037467) Urinalysis macro (dipstick) panel - Urine

5891

45511

2.01

174.43

5.2

4.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3032

19127

1.92

163.37

2.4

2.1

u/l

174.1

215.3

2.52

2847

17987

(3008152) Bicarbonate [Moles/volume] in Arterial blood

928

3713

2.69

153.97

6.3

7.2

mmol/l

24.8

24.5

1.55

841

3459

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3394

22733

1.83

147.46

3.5

3.3

u/l

30.5

34.9

4.09

3229

21545

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4359

31514

1.80

146.56

6.8

6.7

mmol/l

1.2

0.28

3653

26576

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2117

12320

1.96

141.20

4.3

3.5

ng/l

284.3

557.0

1.89

1529

9268

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1094

4961

2.39

138.53

3.2

2.8

ng/l

102.8

174.4

14.78

1006

4493

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6321

51788

1.92

134.91

7.6

7.5

u/l

74.8

77.4

6.23

6051

48885

(3031040) Bacteria [#/volume] in Urine by Automated count

5432

42572

1.79

132.67

5.2

4.0

e6/l

1826.7

1253.7

0.18

541

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1951

11341

1.94

128.85

1.3

iu/ml

23.5

32.0

2.45

674

3574

(3019060) Gas panel - Arterial blood

910

3922

2.48

128.42

5.2

5.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

837

3474

2.57

127.91

7.9

10.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

7884

70831

3.16

127.78

18.7

14.4

mmol/l

139.6

139.7

1.95

7796

69113

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4568

34296

1.74

127.21

5.5

6.4

umol/l

10.1

11.4

18.25

4354

32578

(3023103) Potassium [Moles/volume] in Serum or Plasma

7896

71110

3.17

125.17

18.9

14.6

mmol/l

4.0

6.61

7797

69255

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7720

69160

2.61

115.44

17.1

12.8

mg/l

20.4

23.5

13.81

6461

54035

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1817

10654

1.90

115.17

1.3

1.2

u/ml

8.6

12.4

1.65

572

4324

(42870588) Differential panel, method unspecified - Blood

3221

22547

1.70

110.85

5.6

6.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3377

23965

1.69

110.21

4.1

3.2

ng/l

32.5

45.2

1.87

2173

15411

(3019150) Specific gravity of Urine by Refractometry

2167

13695

1.79

106.62

4.1

3.7

kg/l

1.0

0.55

421

2004

(3026008) Bacteria identified in Urine by Culture

2651

17812

1.72

104.71

3.4

2.9

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7154

62732

2.00

103.28

5.3

4.5

mu/l

1.8

2.2

4.19

6701

57842

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3845

28585

1.64

102.25

5.6

6.0

mmol/l

1.2

0.09

3495

26011

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6203

52172

1.74

101.14

4.4

3.9

pmol/l

14.6

14.7

3.73

5746

47818

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3485

25491

1.63

97.36

2.0

1.9

pmol/l

98.4

96.2

1.78

1832

13459

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1119

5866

2.05

96.62

7.0

8.7

g/l

125.3

122.2

5.43

1038

5659

(40761511) CBC panel - Blood by Automated count

7918

72747

2.83

95.18

17.6

11.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1209

6664

1.95

90.07

1.9

1.7

—

(3016502) Oxygen saturation in Arterial blood

1157

6285

1.98

89.93

6.7

8.3

96.6

95.8

7.28

1084

6066

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1204

6637

1.95

89.64

1.9

1.7

—

(3003396) Base excess in Arterial blood by calculation

1257

7067

1.92

88.13

6.6

7.8

mmol/l

1.6

1.0

9.58

948

5569

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1250

7088

1.90

85.15

6.6

7.8

kpa

5.1

0.02

1167

6786

(3027801) Oxygen [Partial pressure] in Arterial blood

1249

7085

1.90

84.97

6.6

7.8

kpa

12.3

12.7

1.95

1168

6785

(3009542) Hematocrit [Volume Fraction] of Blood

7261

64952

1.93

84.86

18.0

13.8

39.6

40.3

7.33

4624

49285

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1583

9720

1.78

83.07

2.0

1.8

—

(3018010) Neutrophils/100 leukocytes in Blood

4105

32058

1.55

81.55

6.0

56.1

57.0

5.60

3858

30069

(3037522) Nuclear Ab [Titer] in Serum

1499

9109

1.79

81.31

1.4

1.3

titre

426.9

526.7

1.60

300

1844

(3019069) Monocytes/100 leukocytes in Blood

4052

31602

1.55

80.63

6.4

8.4

8.6

2.36

3825

29686

(3006504) Eosinophils/100 leukocytes in Blood

4029

31437

1.55

79.63

6.0

6.1

2.9

1.24

3793

29381

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5689

47963

1.59

79.23

3.8

3.0

u/l

51.4

47.7

2.25

5395

45021

(3044889) 12 lead EKG panel

5699

48080

1.59

79.01

4.2

3.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1994

13217

1.67

78.63

1.8

1.6

pmol/l

75542588.5

31608795.9

1.46

1660

11092

(3002030) Lymphocytes/100 leukocytes in Blood

4139

32545

1.54

78.57

6.0

6.2

29.2

28.2

7.05

3892

30392

(3035350) Ketones [Presence] in Urine by Test strip

4099

32375

1.52

74.73

4.0

3.4

estimate

0.0

1.28

608

5921

(3022096) Basophils/100 leukocytes in Blood

3888

30463

1.52

72.96

6.0

6.2

0.7

0.68

3655

28486

(3009261) Glucose [Presence] in Urine by Test strip

4128

32808

1.51

72.01

4.1

3.4

estimate

0.0

0.12

595

5902

(3019309) Folate [Moles/volume] in Red Blood Cells

1666

10774

1.68

71.21

1.8

1.7

nmol/l

1133.5

1168.0

0.88

1326

8195

(3002385) Erythrocyte distribution width [Ratio]

6598

58195

1.65

70.81

19.3

15.8

13.6

2.62

6510

56959

(3013115) Eosinophils [#/volume] in Blood

4322

34754

1.51

70.77

5.9

6.2

e9/l

0.2

1.46

3957

30589

(3019198) Lymphocytes [#/volume] in Blood

4289

34471

1.50

70.14

5.7

5.9

e9/l

2.0

1.9

1.47

3927

30425

(3006315) Basophils [#/volume] in Blood

4189

33594

1.50

68.62

5.7

5.9

e9/l

0.0

4.03

3791

29058

(3001604) Monocytes [#/volume] in Blood

4171

33467

1.49

67.84

5.6

5.9

e9/l

0.6

2.12

3770

28962

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7370

67202

1.85

67.62

5.0

4.3

mmol/l

5.9

4.47

6901

61921

(3021601) Nitrite [Presence] in Urine by Test strip

4057

32483

1.49

65.94

5.6

4.6

estimate

0.0

0.30

623

6072

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7040

63486

1.71

65.40

6.3

5.2

mmol/mol

39.9

39.2

8.69

6645

59242

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2178

15326

1.57

65.12

2.3

2.2

mg/l

2.6

2.9

7.58

1909

13127

(3020682) Albumin/Creatinine [Ratio] in Urine

2665

19610

1.53

65.09

3.9

mg/mmol

6.8

8.9

1.97

1675

12445

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2099

14680

1.57

64.32

1.8

mg/l

1.0

1.2

2.20

1625

11223

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3261

25215

1.48

61.77

4.3

3.5

—

(3023368) Bacteria identified in Blood by Culture

2322

16744

1.54

61.55

4.3

—

(3012516) Albumin [Mass/volume] in Urine

2534

18647

1.52

60.98

3.2

mg/l

1025.4

396.9

3.71

1547

11775

(3044640) Blood type and Crossmatch panel - Blood

2771

20817

1.50

60.15

2.5

2.3

—

(3009508) Creatinine [Moles/volume] in Urine

2691

20113

1.50

59.81

3.2

3.1

mmol/l

8.0

7.9

0.87

2324

17007

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2454

18121

1.50

57.31

1.9

1.6

mmol/l

1.5

1.4

5.03

2083

15311

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3583

28585

1.45

55.85

3.0

2.8

ug/l

115.2

132.1

4.13

3355

26670

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7914

74640

2.24

55.54

11.8

9.8

u/l

28.2

27.3

3.81

7726

72193

(3042936) Bacteria identified in Isolate by Culture

1379

9004

1.64

55.21

2.2

2.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1966

13961

1.53

54.80

1.6

1.5

nmol/l

21.2

20.4

1.47

1732

12034

(3008898) HLA-B27 [Presence]

493

2332

2.18

54.60

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

978

5869

1.76

53.58

2.2

2.3

nmol/l

361.5

371.9

0.92

890

5421

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2007

14428

1.52

52.45

1.3

1.2

u/ml

1.7

1.8

0.09

432

4031

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

405

1798

2.32

52.26

1.1

u/ml

3.8

7.0

1.12

253

(4010399)

809

4636

1.83

51.71

1.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

4607

38811

1.42

51.35

7.9

9.4

e9/l

4.2

4.1

2.71

4183

33899

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

784

4495

1.82

49.96

2.4

2.3

au/ml

21.8

24.2

0.25

306

(3007853) Bacteria identified in Skin by Aerobe culture

1161

7448

1.65

49.37

1.8

1.7

—

(3018418) pH of Serum or Plasma

2471

18763

1.45

48.27

3.5

4.1

7.4

1.61

403

3669

(3041096) Erythrocytes [Presence] in Urine by Automated

2384

17993

1.46

48.05

3.6

3.0

—

(3007461) Platelets [#/volume] in Blood

8128

78043

2.80

46.28

24.9

18.9

e9/l

254.3

252.4

1.98

8048

76152

(3010813) Leukocytes [#/volume] in Blood

8134

78132

2.84

46.23

24.8

18.9

e9/l

6.8

6.6

15.75

8046

76012

(3035941) MCH [Entitic mass]

8130

78097

2.80

45.78

24.7

18.8

30.4

30.3

6.17

8085

77115

(3026361) Erythrocytes [#/volume] in Blood

8131

78116

2.80

45.68

24.8

18.9

e12/l

4.5

5.18

8044

76025

(3024731) MCV [Entitic volume]

8130

78104

2.79

45.63

24.7

18.8

90.9

0.44

8085

77123

(3000963) Hemoglobin [Mass/volume] in Blood

8130

78136

2.77

44.99

24.9

19.0

g/l

136.7

136.9

0.76

8088

77147

(3003338) MCHC [Mass/volume]

6658

60618

1.49

44.48

20.7

16.3

g/l

334.1

332.9

24.85

6628

60217

(3000330) Specific gravity of Urine by Test strip

562

3003

1.93

44.47

3.4

3.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

712

4107

1.80

44.27

1.3

au/ml

56.0

45.8

0.35

188

(36660697) Celiac disease serology panel - Serum

841

5099

1.72

43.96

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3323

26996

1.38

42.79

2.4

2.2

nmol/l

76.6

0.05

3050

24574

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

346

1564

2.26

42.74

1.3

mg/l

514.9

513.5

0.02

326

1484

(3044290) Cell count panel - Cerebral spinal fluid

300

1293

2.37

41.40

1.2

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1408

9842

1.52

40.65

1.9

2.2

28.8

29.8

6.26

1319

9554

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

309

1362

2.32

40.50

1.2

1.3

mmol/l

3.7

0.07

284

1280

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

573

3205

1.85

39.28

2.6

2.4

—

(3017732) Neutrophils [#/volume] in Blood

772

4710

1.70

39.26

2.8

2.9

e9/l

4.0

4.1

0.21

635

3760

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7439

69798

1.62

39.12

4.9

4.2

mmol/l

4.7

0.61

7029

65295

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7529

70896

1.65

38.49

5.4

4.6

mmol/l

2.8

3.08

7082

65948

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1140

7719

1.55

37.88

1.5

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

1203

8252

1.54

37.66

2.1

2.4

ug/g

140.5

131.8

0.28

957

6544

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

302

1376

2.24

36.60

1.3

1.4

e6/l

56.0

22.9

0.41

251

1028

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

301

1378

2.23

36.06

1.3

1.4

e6/l

2528.0

1161.5

0.31

261

1095

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

715

4405

1.68

34.91

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

470

2574

1.88

34.37

1.2

u/ml

1.1

1.0

0.06

235

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7366

69362

1.54

33.45

4.8

4.2

mmol/l

1.4

1.5

10.22

6936

64593

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2146

16744

1.38

33.33

2.9

ng/l

834.0

1199.8

4.41

1792

14291

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

110

311

3.57

32.99

1.2

1.3

67.9

69.0

0.04

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

145

488

3.01

32.79

1.1

mg/l

41.4

40.9

0.03

114

409

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

460

2552

1.85

32.28

1.1

u/ml

7.7

2.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

141

472

3.02

32.19

1.1

mg/l

290.0

269.5

0.26

123

418

(3026389) Candida sp identified in Specimen by Organism specific culture

209

879

2.41

30.52

1.6

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2233

17738

1.35

30.42

2.7

2.5

umol/l

3558.0

4038.0

0.25

1966

15570

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

133

449

2.99

29.94

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

479

2759

1.78

29.68

3.7

3.4

mmol/l

25.6

25.2

1.12

443

2673

(3019897) Erythrocyte distribution width [Ratio] by Automated count

234

1052

2.26

29.33

3.2

2.6

13.4

13.1

2.75

234

1031

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

153

564

2.74

29.32

1.0

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

289

1417

2.08

29.09

1.3

1.4

—

(40768797) Stomach Pathology biopsy report

1252

9087

1.44

28.97

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

590

3635

1.67

28.66

3.7

3.4

g/l

131.6

130.2

0.75

563

3555

(4027681)

113

361

3.16

27.99

1.3

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

655

4170

1.62

27.93

1.4

1.3

u/ml

170.8

229.1

1.71

601

3857

(3022621) pH of Urine by Test strip

647

4116

1.62

27.67

2.8

2.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2002

15899

1.34

26.68

2.5

2.3

—

(3013512) EKG study

2272

18394

1.32

26.47

4.6

3.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1316

9792

1.41

26.29

2.3

2.5

umol/l

13.7

13.5

0.50

1216

9147

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

476

2838

1.72

26.10

2.0

u/l

40.6

39.5

0.62

423

2538

(3017704) Immunofixation for Urine

100

310

3.25

26.06

1.5

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5101

45948

1.28

25.72

3.0

2.9

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

360

1999

1.84

25.18

1.6

1.8

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

337

1840

1.87

24.87

1.3

u/ml

22.0

37.6

0.82

120

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

267

1348

2.01

24.84

1.3

1.2

u/ml

5.7

3.2

0.24

(3045414) Leukocytes [Presence] in Urine

478

2893

1.69

24.80

1.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

747

5046

1.53

24.53

2.5

2.6

g/l

10.1

10.6

3.42

673

4637

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

108

364

2.99

24.46

1.8

1.4

u/l

5.4

6.4

0.82

311

(3020191) Ethanol [Moles/volume] in Serum or Plasma

146

577

2.56

24.43

1.8

1.4

promille

1.4

0.04

123

439

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

679

4498

1.55

24.36

3.0

3.9

ng/l

77.6

91.0

3.10

602

3908

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1211

9022

1.40

23.81

2.3

2.5

g/l

2.4

2.3

7.02

1118

8422

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

214

1011

2.15

23.79

1.3

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

101

339

3.00

23.07

1.1

u/l

1.1

0.01

160

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1053

7698

1.42

23.02

2.4

2.9

umol/l

6.5

8.5

3.54

897

6713

(3020630) Protein [Mass/volume] in Serum or Plasma

734

5015

1.51

22.79

2.4

2.5

g/l

67.3

66.6

1.84

662

4623

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

402

2381

1.72

22.57

2.1

2.0

ug/l

1.8

2.2

0.21

343

2136

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

201

949

2.15

22.40

1.4

—

(3000494) Fungus identified in Specimen by Culture

1067

7862

1.41

22.26

1.6

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

178

803

2.24

22.21

1.3

u/ml

71.0

64.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

307

1692

1.85

22.01

1.3

u/ml

6.6

5.8

0.07

263

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1215

9172

1.38

21.93

1.9

1.8

1.5

1.4

3.51

1072

8128

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

304

1676

1.84

21.78

1.3

u/ml

2.9

5.5

0.60

158

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

221

1094

2.05

21.75

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

350

2015

1.77

21.72

3.6

2.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

182

841

2.19

21.43

6.6

6.4

mg/l

11.5

11.3

0.25

167

779

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1121

8390

1.39

21.27

2.3

2.6

23.2

23.4

0.09

803

7232

(3004588) Protein electrophoresis panel - Serum or Plasma

611

4076

1.54

21.18

2.3

2.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

336

2.91

20.99

1.2

1.4

nmol/l

1.3

1.2

0.51

257

(1761482) Bacteria [#/volume] in Urine by Culture

272

1467

1.88

20.89

4.3

3.9

—

(3037756) Immunofixation for Serum or Plasma

233

1194

1.98

20.84

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1558

12310

1.33

20.75

1.6

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

176

820

2.17

20.33

1.4

—

(3023419) Bacteria identified in Sputum by Culture

166

757

2.22

20.22

3.0

2.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

259

1391

1.89

20.17

1.3

1.2

u/ml

61.0

38.6

1.01

135

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

121

486

2.51

19.66

1.2

1.3

mmol/l

1.9

2.0

0.85

111

455

(3014051) Protein [Presence] in Urine by Test strip

259

1425

1.84

18.72

2.0

2.1

—

(44806118)

152

691

2.22

18.69

1.6

1.5

—

(44790049)

152

691

2.22

18.69

1.6

1.5

—

(44790048)

152

691

2.22

18.69

1.6

1.5

—

(44790047)

152

691

2.22

18.69

1.6

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

159

737

2.18

18.64

1.7

1.6

57.0

56.7

0.03

100

467

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2616

22325

1.25

18.61

4.8

4.4

ug/l

2.4

2.8

0.35

2417

20273

(3023520) Reticulocytes [#/volume] in Blood

696

4897

1.46

18.56

2.3

2.6

e9/l

69.5

70.8

0.37

573

3643

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

232

1241

1.89

18.32

1.8

1.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

314

1841

1.73

18.32

1.5

1.4

ug/g

277.5

277.4

0.00

174

1037

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

610

4196

1.49

18.24

2.8

3.4

pmol/l

4.5

0.05

544

3756

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1334

10482

1.32

18.22

3.1

3.5

mmol/l

0.8

0.01

1243

9857

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

108

431

2.53

17.83

1.2

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

532

3575

1.52

17.80

3.4

3.2

mmol/l

1.9

1.7

0.88

402

2659

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7035

67073

1.32

17.53

4.2

3.8

mmol/l

1.4

1.3

21.68

6600

62104

(3015377) Calcium [Moles/volume] in Serum or Plasma

2518

21547

1.24

17.15

2.8

3.5

mmol/l

2.3

2.4

1.65

2218

18989

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

550

3755

1.50

17.05

3.5

3.3

kpa

5.2

5.1

0.94

508

3482

(3009343) pH of Capillary blood

544

3707

1.50

17.02

3.5

3.3

7.4

0.46

469

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1057

8116

1.35

16.81

5.0

6.0

mmol/l

1.0

0.60

983

7593

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

404

2591

1.59

16.65

2.2

1.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

260

1500

1.76

16.09

1.7

1.6

e6/l

11371.0

14427.8

0.50

197

1068

(3026782) Osmolality of Urine

1526

12396

1.28

16.06

2.8

2.7

mosm/kgh2o

537.4

549.2

1.23

1308

10544

(3009214) Lutropin [Units/volume] in Serum or Plasma

311

1888

1.67

16.00

1.4

1.3

u/l

10.2

10.4

0.06

263

1564

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

518

3549

1.49

15.78

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

115

3.93

15.78

1.2

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

338

2112

1.63

15.53

2.2

u/l

8726.4

4574.1

0.89

835

(3025941) Bacteria identified in Stool by Culture

545

3791

1.47

15.39

1.3

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

284

1701

1.69

15.38

1.5

1.4

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

292

2.72

15.27

1.5

1.6

nmol/l

76.5

13.6

0.43

233

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

277

2.76

15.09

2.3

2.1

umol/l

80.8

164.7

2.41

142

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

256

1499

1.73

15.06

1.8

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1561

12811

1.27

15.00

1.5

1.4

g/l

2.4

0.76

967

8077

(3011288) Drugs identified in Urine by Screen method

271

1617

1.70

14.90

3.5

2.9

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

389

2542

1.56

14.80

4.2

3.9

48.5

49.5

0.33

383

2512

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

323

2024

1.62

14.69

1.6

g/l

1.2

0.74

301

1928

(3027945) Reticulocytes/100 erythrocytes in Blood

869

6605

1.35

14.69

2.3

2.5

1.7

1.8

0.60

770

5890

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

860

6527

1.35

14.67

3.8

3.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

314

1956

1.63

14.63

1.6

1.7

g/l

0.2

0.29

291

1858

(3023511) Choriogonadotropin [Units/volume] in Urine

192

1041

1.86

14.62

1.4

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

250

1467

1.73

14.61

1.9

1.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

335

2123

1.60

14.55

2.1

2.4

ug/l

296.6

597.0

1.86

317

2004

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

127

596

2.15

14.53

1.3

1.6

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

145

3.39

13.92

1.4

1.2

36.5

38.3

0.11

102

(3006653) Thiamine [Moles/volume] in Blood

314

2.56

13.77

1.4

1.3

nmol/l

141.6

135.6

0.56

314

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2085

17869

1.22

13.30

4.6

3.8

21.6

21.7

0.13

842

8104

(3044941) Cell count panel - Synovial fluid

178

975

1.84

13.17

1.5

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

116

548

2.13

13.10

1.4

1.3

e6/l

66400.4

69380.3

0.02

383

(3044927) Protein electrophoresis panel - Urine

116

560

2.09

12.40

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

154

828

1.88

12.12

1.4

pmol/l

296.4

323.0

0.24

113

628

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

905

7112

1.31

12.05

3.6

4.5

u/l

234.2

239.8

0.68

852

6758

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

168

2.99

11.60

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

594

4429

1.37

11.31

1.2

—

(3002032) Base excess in Venous blood by calculation

718

5518

1.33

11.20

3.5

3.9

mmol/l

2.3

1.9

2.63

579

4523

(3000850) Epithelial cells [#/volume] in Urine

1575

13328

1.22

11.11

2.7

2.5

e6/l

5.6

5.5

0.11

1385

11617

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

178

2.88

11.08

5.7

7.3

—

(3011985) Renin [Units/volume] in Plasma

159

890

1.80

11.04

1.3

1.5

mu/l

51.9

58.1

0.22

143

798

(3006184) Hemoglobin [Mass/volume] in Capillary blood

222

1365

1.64

10.99

1.9

2.1

g/l

132.0

130.5

0.37

181

969

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

241

2.58

10.97

1.0

1.1

ng/l

238.3

291.7

0.16

(3040151) Glucose [Moles/volume] in Capillary blood

120

615

1.97

10.94

3.2

5.2

mmol/l

8.3

7.1

0.55

100

522

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6337

66013

0.83

10.91

14.0

12.0

ml/min/173m2

84.6

83.4

5.20

5282

54546

(3022313) Gas panel - Capillary blood

387

2703

1.45

10.75

3.7

3.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

344

2353

1.48

10.64

4.0

3.3

mmol/l

24.9

24.8

0.13

324

2153

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

607

4593

1.35

10.52

1.2

iu/ml

127.7

154.5

1.07

246

1767

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

164

943

1.75

10.42

1.2

1.3

nmol/l

0.6

2.5

0.85

157

910

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

184

1093

1.70

10.41

1.1

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

816

6449

1.29

10.37

2.0

1.9

—

(3022145) Colonoscopy Study observation

945

7613

1.27

10.31

1.3

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

221

1381

1.62

10.28

3.2

3.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1744

15021

1.20

10.16

4.1

3.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

222

2.58

10.08

5.2

7.1

mmol/l

25.0

25.1

0.06

205

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

895

7184

1.28

10.06

2.1

1.9

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

710

5532

1.31

10.03

3.6

3.9

kpa

5.8

0.02

684

5377

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

133

727

1.84

10.02

2.2

2.1

mg/l

24.6

21.1

0.34

201

(3003181) Sodium [Moles/volume] in Urine

171

1010

1.71

9.90

1.4

1.3

mmol/l

62.2

63.5

0.16

145

810

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1093

13166

0.80

9.89

2.8

ug/l

0.7

2.18

664

8228

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

337

2333

1.46

9.83

2.5

2.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

337

2333

1.46

9.83

2.5

2.1

g/l

3.8

0.26

190

1713

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

318

2177

1.48

9.82

2.5

2.2

g/l

9.6

10.3

2.78

235

1861

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

337

2336

1.46

9.77

2.5

2.1

g/l

7.3

7.4

0.23

196

1792

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

303

2057

1.49

9.75

1.6

iu/ml

15.0

0.3

0.49

445

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

110

571

1.94

9.72

2.4

2.9

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

127

3.08

9.60

6.3

7.5

—

(3004451) EKG impression Narrative

289

2.33

9.54

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

418

3027

1.40

9.53

1.9

1.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

194

1197

1.64

9.53

1.7

1.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

160

2.82

9.50

5.7

7.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

143

813

1.77

9.49

1.4

1.5

—

(3019225) pH of Specimen

766

6090

1.28

9.28

4.2

4.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

250

2.41

9.24

2.1

7.9

9.3

0.76

237

(40767503) Oxygen content in Capillary blood by calculation

209

1328

1.59

9.12

2.4

2.5

16.5

0.02

116

656

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

167

1007

1.67

8.99

1.3

mmol/l

6.9

7.3

0.88

109

759

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

159

947

1.69

8.97

1.2

1.3

nmol/l

0.3

0.00

(4024509)

106

561

1.90

8.88

1.7

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

121

671

1.82

8.76

2.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

169

1032

1.65

8.69

1.4

1.3

u/l

25.6

30.5

1.14

131

853

(3015235) Bicarbonate [Moles/volume] in Capillary blood

225

1472

1.54

8.67

2.5

3.1

mmol/l

25.0

24.7

0.36

206

1285

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

505

3832

1.34

8.61

2.0

1.9

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

141

2.85

8.61

2.0

2.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

248

1663

1.51

8.53

2.1

1.9

pmol/l

196.9

201.9

0.31

234

1584

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

248

2.35

8.47

2.1

2.0

29.7

28.7

0.20

238

(3045424) Erythrocytes [Presence] in Urine

180

1125

1.61

8.45

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

137

797

1.73

8.45

1.4

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.16

8.44

1.1

1.2

umol/24h

1.5

1.6

0.28

(3035637) Corticotropin [Mass/volume] in Plasma

140

820

1.72

8.42

1.4

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

454

3405

1.35

8.37

1.4

1.3

iu/l

30.8

31.7

0.22

413

2953

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

482

1.94

8.32

1.5

1.3

u/ml

1.2

1.5

0.19

216

(3030981) Hyaline casts [#/volume] in Urine by Automated count

431

3214

1.36

8.25

2.6

e6/l

0.3

0.07

413

3118

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

442

1.98

8.25

2.4

2.7

e9/l

0.2

0.21

382

(3020491) Glucose [Moles/volume] in Blood

456

1.96

8.23

2.2

2.0

mmol/l

6.5

6.6

0.12

319

(3025468) Yersinia sp identified in Specimen by Organism specific culture

136

796

1.72

8.22

1.4

1.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

233

2.37

8.21

1.1

1.2

g/l

0.3

0.43

187

(3025577) Chromium [Mass/volume] in Blood

337

2.12

8.09

2.3

2.0

ug/l

2.7

2.4

0.15

289

(3024522) Salmonella sp identified in Specimen by Organism specific culture

136

800

1.71

8.08

1.4

1.5

—

(21494755) Public health laboratory ask at order entry panel

664

8280

0.78

8.06

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

264

1816

1.47

8.03

2.3

2.0

mg/l

10.6

11.2

0.70

244

1697

(3024980) IgG subclass 4 [Mass/volume] in Serum

179

1132

1.59

8.02

1.4

1.6

g/l

0.7

0.8

0.10

102

870

(3021788) Differential panel - Synovial fluid

183

1164

1.59

8.01

1.7

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

275

1910

1.45

7.96

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

311

2210

1.42

7.95

1.6

titre

279.2

340.2

0.11

(3017446) Testosterone [Moles/volume] in Serum or Plasma

692

5538

1.27

7.95

2.6

2.2

nmol/l

12.4

13.2

2.13

614

4989

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

135

801

1.70

7.79

1.4

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

1936

17164

1.17

7.76

4.7

3.8

estimate

0.0

0.27

614

5823

(3005988) Vibrio sp identified in Specimen by Organism specific culture

135

802

1.69

7.75

1.4

1.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

128

2.82

7.66

1.9

2.0

umol/l

13.6

16.9

1.13

128

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

258

1784

1.46

7.66

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

306

2185

1.42

7.63

1.6

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

315

2262

1.41

7.61

1.6

mu/l

252.1

299.6

3.63

287

2048

(3033923) Metanephrine [Moles/time] in 24 hour Urine

118

2.89

7.56

1.1

1.2

umol/24h

0.5

0.7

2.46

(3004616) Nuclear Ab [Presence] in Serum

132

785

1.69

7.56

1.4

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

275

1932

1.44

7.51

3.0

2.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

507

3945

1.30

7.27

1.9

g/l

1.4

1.3

0.29

468

3626

(3008116) Ketones [Moles/volume] in Urine by Test strip

121

2.82

7.24

1.6

1.4

—

(3033658) Prothrombin time (PT) actual/Normal

1948

17366

1.16

7.18

3.5

3.9

96.4

91.3

18.03

1876

16959

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

115

669

1.73

7.16

1.2

1.1

—

(36304419) Bacteria [Presence] in Urine

1962

17515

1.16

7.08

3.3

3.0

—

(3008295) Osmolality of Serum or Plasma

110

634

1.74

7.08

1.4

mosm/kgh2o

276.8

279.8

0.77

508

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

474

1.87

7.08

1.5

2.0

nmol/l

17.5

18.1

0.25

456

(4035726)

483

6166

0.77

7.08

1.3

1.4

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

5.66

7.06

1.3

1.1

mg/l

0.0

0.58

(3000764) Benzodiazepines [Presence] in Urine

343

2532

1.37

7.05

2.6

2.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

927

7767

1.22

7.03

7.0

6.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

203

1365

1.50

6.97

2.3

2.9

umol/l

28.6

35.2

5.06

172

1172

(3010421) pH of Blood

242

1688

1.45

6.90

4.7

4.2

7.4

0.11

207

1425

(3034860) Kappa light chains.free [Mass/volume] in Serum

263

1863

1.43

6.90

3.2

mg/l

35.4

86.4

1.00

205

1499

(3028300) Cannabinoids [Presence] in Urine

344

2551

1.36

6.88

2.7

2.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

315

2304

1.38

6.86

2.0

1.7

nmol/l

39.4

40.3

0.36

305

2246

(3024139) IgG subclass 3 [Mass/volume] in Serum

118

701

1.69

6.83

1.3

g/l

0.4

0.40

489

(3027135) IgG subclass 1 [Mass/volume] in Serum

118

701

1.69

6.83

1.3

g/l

6.9

6.8

0.16

489

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

257

1818

1.43

6.80

3.2

3.1

ratio

1.4

2.3

—

142

(3028192) IgG subclass 2 [Mass/volume] in Serum

118

702

1.69

6.80

1.3

g/l

3.0

0.02

490

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

300

2.07

6.79

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

368

1.96

6.79

1.2

—

(3016879) Cocaine [Presence] in Urine

319

2345

1.37

6.75

2.7

2.1

—

(3002582) Erythrocytes [#/volume] in Urine

2164

19515

1.15

6.73

3.5

3.1

e6/l

42.9

83.5

2.44

1737

14779

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

262

1864

1.42

6.72

3.2

mg/l

31.8

45.3

1.64

203

1505

(3017181) Myelocytes/100 leukocytes in Blood

684

5577

1.25

6.72

3.2

4.2

0.9

0.08

189

1554

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.50

6.70

2.2

2.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

137

851

1.62

6.69

1.2

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

615

7569

0.80

6.65

1.8

1.7

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

121

730

1.67

6.63

1.1

1.3

—

29.2

—

(4062490)

117

700

1.68

6.61

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

113

670

1.70

6.60

1.9

1.7

—

(3012501) Base excess in Blood by calculation

211

1448

1.47

6.57

4.9

4.2

mmol/l

2.5

0.01

154

974

(1616796) Gas panel - Central venous blood

202

1375

1.48

6.55

3.9

3.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

241

1697

1.43

6.55

1.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

187

1254

1.50

6.53

2.4

2.9

kpa

8.0

8.2

1.08

179

1156

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

459

1.84

6.49

2.4

2.7

e6/l

580.2

514.2

0.51

387

(3026470) Cobalt [Mass/volume] in Blood

347

1.97

6.46

2.2

2.0

ug/l

4.9

3.3

0.43

302

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

515

0.27

6.46

26.0

12.4

nmol/l

916.0

874.7

0.13

491

(3028707) Methadone [Presence] in Urine by Screen method

161

1048

1.55

6.46

3.9

2.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

482

1.81

6.44

1.9

2.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

529

0.28

6.42

29.8

18.0

nmol/l

1552.4

3283.8

0.47

510

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

148

947

1.57

6.40

1.1

g/l

1.5

0.22

131

862

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

3.29

6.40

1.1

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

138

870

1.60

6.36

1.4

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

391

1.90

6.36

2.4

2.8

40.2

40.5

0.05

131

(3027008) Opiates [Presence] in Urine

339

2547

1.35

6.26

2.6

1.9

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

193

1316

1.48

6.23

2.0

1.9

nmol/l

0.9

0.8

0.88

165

1129

(3004775) Volume in Urine collected for unspecified duration

451

1.83

6.23

2.1

2.2

607.1

654.0

0.52

314

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

366

1.92

6.21

1.0

1.1

nmol/l

0.1

10.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

244

2.14

6.20

2.6

2.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

168

2.39

6.18

1.1

1.2

nmol/l

154.4

115.4

0.70

126

(3017143) Hepatitis C virus Ab [Presence] in Serum

933

7919

1.20

6.18

1.5

1.6

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

115

2.70

6.16

1.3

mg/l

0.7

117.8

1.20

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

446

3500

1.29

6.05

1.8

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

328

1.96

6.03

1.0

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

395

3063

1.30

5.87

1.1

titre

129.4

236.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.40

5.85

2.3

2.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1239

10825

1.17

5.84

1.5

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

1984

17935

1.14

5.83

3.4

3.0

e6/l

0.3

0.4

1.10

1577

13288

(3021901) Oxygen saturation in Capillary blood

160

1067

1.51

5.79

2.4

2.8

—

(3025159) Blasts/100 leukocytes in Blood

613

5026

1.24

5.75

3.3

4.3

0.1

0.2

0.55

156

1225

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

286

2.00

5.72

1.1

—

(3027944) Amphetamines [Presence] in Urine

330

2505

1.33

5.72

2.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

550

4459

1.25

5.71

3.1

kpa

4.5

4.7

1.06

529

4316

(3003694) ABO and Rh group [Type] in Blood

2127

19336

1.13

5.71

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

295

2208

1.35

5.63

2.6

2.2

g/l

2.9

3.1

1.68

195

1758

(3034891) Synovial lining cells/100 cells in Synovial fluid

296

1.97

5.56

1.8

1.5

2.8

4.2

0.27

(40757373) Influenza virus identified in Isolate

116

2.59

5.53

1.3

1.8

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.85

5.50

7.1

9.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

375

1.85

5.49

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

111

2.62

5.46

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

334

1.89

5.42

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

218

2.12

5.39

1.1

96.0

88.7

1.40

107

(3049717) Cytology report of Urine Cyto stain

295

2233

1.33

5.25

2.5

2.6

—

(1175426) CD3 cells/100 lymphocytes in Blood

522

1.69

5.23

1.9

2.1

73.9

73.1

0.19

504

(3011412) CD3 cells [#/volume] in Blood

105

653

1.62

5.20

2.2

2.5

e9/l

1.3

1.1

0.92

393

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

383

1.81

5.16

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

127

2.45

5.11

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

512

1.69

5.05

1.9

2.1

14.4

14.3

0.03

234

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

424

1.75

4.99

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1696

15313

1.14

4.99

4.3

4.4

—

(3023410) Appearance of Cerebral spinal fluid

102

638

1.61

4.95

1.3

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

226

2.04

4.94

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

617

1.61

4.89

2.0

1.8

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

222

1628

1.37

4.88

1.7

1.9

iu/l

4.0

4.4

0.26

633

(40761536) Microorganisms panel - Urine sediment

669

5635

1.20

4.83

4.7

3.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

162

2.23

4.83

1.3

1.2

g/l

38.4

39.4

0.14

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

222

2.03

4.79

2.4

2.0

ug/l

69.6

61.9

0.30

217

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

422

1.74

4.79

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

475

1.69

4.77

1.3

1.2

u/ml

1.6

5.5

—

(3037121) Protein [Mass/volume] in Urine

277

2110

1.32

4.75

3.1

3.2

g/l

0.4

0.3

0.64

949

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

920

7982

1.17

4.72

4.8

4.2

30.8

31.9

2.27

681

5532

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

217

2.03

4.70

1.1

1.2

116.3

104.6

1.11

199

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

197

2.09

4.69

1.3

1.2

17.2

22.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

348

2740

1.28

4.67

2.8

2.9

0.7

0.65

333

2629

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

301

1.87

4.67

2.3

umol/l

54.7

52.6

0.14

252

(3019420) Tryptase [Mass/volume] in Serum or Plasma

359

1.79

4.66

1.6

ug/l

8.2

8.1

0.02

326

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

212

2.03

4.60

1.1

1.2

105.5

88.1

2.93

105

(4094501)

261

1983

1.33

4.57

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

143

982

1.46

4.57

1.3

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

623

5242

1.20

4.56

3.6

3.9

mmol/l

1.2

0.50

542

4606

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

119

789

1.52

4.52

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

113

742

1.53

4.49

1.8

1.6

—

(3006270) Folate [Moles/volume] in Blood

522

1.63

4.48

1.2

1.1

nmol/l

328.5

384.4

2.02

448

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

320

1.82

4.47

1.4

1.9

125.4

148.5

2.38

300

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

492

1.65

4.46

1.3

1.2

u/ml

96.1

37.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

126

848

1.49

4.46

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

549

1.61

4.37

1.8

1.5

26.4

30.7

0.52

326

(3003888) Timothy IgE Ab [Units/volume] in Serum

171

1229

1.40

4.29

1.1

u/ml

4.0

5.3

0.54

610

(3016750) Collection duration of Urine

332

1.78

4.28

1.9

2.2

min

490.2

496.3

0.16

256

(44813793)

460

1.66

4.26

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

338

2685

1.27

4.26

1.6

1.7

g/l

1.5

0.07

300

2304

(3002179) Metamyelocytes/100 leukocytes in Blood

604

5102

1.20

4.26

3.0

4.1

0.8

0.6

0.66

147

1136

(3021440) Promyelocytes/100 leukocytes in Blood

625

5297

1.19

4.25

3.4

4.3

0.1

0.04

177

1435

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

226

1.95

4.23

1.2

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

408

1.70

4.22

1.1

iu/ml

5.4

10.3

1.14

116

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

416

1.69

4.21

1.2

ratio

1.0

1.1

0.02

143

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

611

5173

1.20

4.20

2.4

2.2

ug/l

6.4

8.3

1.36

527

4582

(40768800) Prostate Pathology biopsy report

1383

0.65

4.14

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

143

1004

1.43

4.11

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1333

11994

1.13

4.09

1.8

—

(3016018) Differential panel - Cerebral spinal fluid

107

710

1.51

4.09

1.3

1.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

330

1.76

4.08

1.1

u/ml

6.0

13.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

3.08

4.07

4.4

4.5

—

(3022806) Fractional oxyhemoglobin in Capillary blood

122

833

1.47

4.06

2.0

1.8

90.0

89.7

0.28

122

821

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

468

3880

1.22

4.02

7.1

7.6

mmol/l

25.1

24.7

1.81

463

3858

(4281824)

776

0.54

4.00

1.1

1.2

—

(4034850)

156

2146

0.72

3.97

9.7

8.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

225

1.92

3.94

1.4

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

395

1.68

3.90

1.4

1.5

u/ml

20.4

20.8

0.02

(4133840)

206

1.95

3.85

1.1

1.2

—

(3002256) Pathology report gross observation

782

8940

0.86

3.81

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

403

3311

1.23

3.80

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

415

5006

0.82

3.78

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

173

2.03

3.78

4.9

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

173

2.03

3.78

4.9

2.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

493

1.59

3.73

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

493

1.59

3.73

1.1

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

316

2536

1.26

3.70

1.7

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

494

1.58

3.70

1.1

1.2

—

(4198724)

296

1.76

3.69

1.9

2.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

187

1401

1.34

3.68

2.0

1.7

—

(3021589) Normoblasts [#/volume] in Blood

2834

30043

0.91

3.66

11.2

9.3

e9/l

0.0

2.70

2413

24538

(3019977) pH of Arterial blood

327

1.72

3.64

4.4

2.7

7.4

0.16

113

(40759836) Histone Ab [Presence] in Serum by Immunoblot

489

1.58

3.62

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

489

1.58

3.62

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

490

1.58

3.59

1.1

1.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

7.78

3.55

1.6

1.3

mmol/l

4.2

4.6

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.50

3.54

1.6

1.3

mmol/l

2.0

1.9

0.01

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

179

1347

1.34

3.45

1.1

u/ml

0.5

1.4

3.05

520

(4146454)

624

1.50

3.44

2.9

2.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

543

0.50

3.42

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

146

2.06

3.40

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

146

2.06

3.40

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

146

2.06

3.40

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

146

2.06

3.40

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1218

11022

1.12

3.40

3.0

2.7

e6/l

1.2

1.1

0.15

783

6132

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

191

2485

0.76

3.39

1.4

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

508

1.54

3.32

1.1

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1421

0.69

3.30

1.4

1.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.54

3.29

1.0

1.1

—

(3018095) Leukocytes [#/volume] in Urine

2440

22910

1.09

3.28

3.9

3.6

e6/l

72.9

87.4

0.53

1861

15997

(44816559) Phosphatidylethanol [Mass/volume] in Blood

177

1342

1.33

3.26

1.7

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

122

2.13

3.25

1.6

1.9

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

256

1.76

3.24

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

141

1034

1.37

3.24

1.1

au/ml

12.5

13.3

—

(40768793) Breast Pathology biopsy report

109

1532

0.71

3.23

1.2

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

163

1.97

3.23

1.0

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

170

1.94

3.22

1.1

u/ml

0.8

1.4

0.34

(3000034) Microalbumin [Mass/volume] in Urine

610

1.48

3.19

2.7

3.0

mg/l

24.8

68.2

1.54

444

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

703

6169

1.15

3.16

2.1

2.3

g/l

0.2

2.68

635

5752

(3000492) Spirometry study

788

6974

1.14

3.14

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1101

9953

1.12

3.13

1.5

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

2.47

3.12

1.1

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.08

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

235

1866

1.27

3.08

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

298

1.68

3.07

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

298

1.68

3.07

1.4

1.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

224

1770

1.27

3.05

1.4

iu/ml

12.6

14.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

7.51

3.05

1.8

1.0

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

224

1.79

3.05

2.4

1.9

u/ml

157573.3

16553.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

405

3410

1.20

3.04

1.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

625

1.46

3.04

1.9

2.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

217

1.80

3.04

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

518

0.52

3.01

1.1

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.30

3.00

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

394

1.58

2.97

1.5

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

235

1875

1.26

2.97

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

156

1181

1.33

2.94

1.1

u/ml

0.7

1.4

1.62

476

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

185

1435

1.30

2.93

2.1

2.4

ug/min

105.9

104.4

0.01

108

882

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

170

1.89

2.89

1.0

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

231

1848

1.26

2.87

1.2

—

(40768804) Tissue Pathology biopsy report

2677

28222

0.92

2.86

2.0

—

(3014271) Vancomycin [Susceptibility]

259

1.70

2.85

2.8

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

171

1.87

2.84

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

157

1.91

2.84

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1133

0.69

2.83

1.4

1.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.06

2.80

1.1

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

349

4143

0.84

2.76

1.6

1.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

474

1.50

2.76

1.9

1.7

—

(3016038) Potassium [Moles/volume] in Urine

372

1.56

2.71

1.2

mmol/l

33.4

35.3

0.24

325

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.24

2.69

1.2

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

143

1085

1.32

2.69

2.0

1.7

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

310

1.62

2.69

1.6

1.7

u/field

3.0

0.00

227

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

105

2.10

2.68

1.1

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

651

1.42

2.67

3.4

4.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

168

1.85

2.66

1.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

250

1.68

2.64

3.5

10.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

306

1.60

2.57

1.1

93.3

96.9

0.47

243

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

166

1295

1.29

2.57

1.3

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

154

1190

1.30

2.56

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1096

0.70

2.54

1.4

—

(4211845)

315

1.59

2.54

3.0

3.1

—

(4015189)

157

1.85

2.51

2.0

2.2

—

(3042631) Mycobacterium sp identified in Specimen

112

829

1.36

2.51

2.7

2.6

—

(3015183) Erythrocyte sedimentation rate

381

1.53

2.47

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

406

1.51

2.44

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.67

2.44

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

130

1.93

2.44

1.4

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

631

1.40

2.40

3.2

3.7

57.0

57.1

0.01

410

(3042517) Benzodiazepines panel - Urine

2.29

2.40

1.9

2.1

—

(3005033) Fetal Nuchal fold Thickness US

1093

0.71

2.37

1.4

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

6.25

2.37

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.75

2.37

2.3

1.7

umol/l

51.5

41.3

0.55

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.42

2.36

1.0

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

559

1.42

2.34

1.2

1.0

mg/l

292.4

283.8

0.61

504

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

138

1066

1.30

2.33

1.1

127.8

117.1

3.35

125

968

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

184

1.74

2.31

1.1

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

706

1.36

2.27

1.7

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

132

1018

1.30

2.27

2.7

3.6

1.2

1.5

0.66

113

790

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.48

2.26

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

325

1.54

2.26

1.4

1.6

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

113

1.95

2.24

1.5

1.2

mmol/l

2.3

1.8

0.78

(40761539) Cells [Type] in Urine sediment by Light microscopy

164

1.77

2.22

1.1

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

352

0.51

2.22

1.0

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.34

2.21

1.2

mmol/l

5.6

5.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

351

1.51

2.21

1.6

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

180

1.72

2.18

2.1

e6/l

137.5

252.0

0.47

(3016650) Hepatitis A virus Ab [Presence] in Serum

147

1159

1.27

2.15

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

354

1.50

2.13

1.6

1.5

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

388

1.47

2.10

1.4

2.3

112.0

95.9

2.65

364

(3036603) Volume of Urine

446

1.44

2.09

1.8

1.7

1975.3

2038.1

0.12

(3017817) Protein [Mass] in Urine collected for unspecified duration

572

1.38

2.09

2.2

2.5

—

(40757494) Bilirubin.total [Moles/volume] in Blood

324

1.52

2.07

1.9

2.5

umol/l

24.1

30.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

439

1.44

2.06

1.9

u/field

1.7

1.6

0.06

183

(3025315) Body weight

0.00

2.06

0.0

3.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

482

5442

0.88

2.05

2.0

2.6

ml/min/173m2

69.8

67.9

0.47

190

2078

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

309

1.52

2.04

1.1

miu/ml

1342.5

1521.5

0.51

309

(40761535) Cells panel - Urine sediment

561

5011

1.13

2.02

4.1

3.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

272

2304

1.19

2.02

1.8

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

492

0.61

2.02

1.5

1.4

—

69.0

—

(3035933) Granulocytes/100 leukocytes in Blood

200

1.65

2.01

1.6

1.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

279

1.54

1.99

1.8

2.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

865

7926

1.10

1.97

16.1

22.6

inr

1.2

1.3

1.95

1162

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

3.34

1.96

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

125

979

1.28

1.96

1.1

u/ml

2.4

3.5

0.92

505

(3028433) Virus identified in Specimen by Culture

225

1.60

1.95

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

233

1.59

1.95

1.8

1.9

mg/l

7.0

9.7

2.81

190

(3006462) Nitrate [Presence] in Urine

289

1.53

1.94

3.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

154

1240

1.25

1.92

2.4

3.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

131

1647

0.79

1.92

1.5

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

242

1.57

1.92

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1110

10303

1.09

1.91

3.1

2.8

e6/l

3.0

2.5

0.68

672

5452

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

227

1.59

1.89

1.3

1.5

pmol/l

14.0

15.6

0.88

195

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

101

1307

0.77

1.88

1.3

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

123

968

1.27

1.87

3.0

2.9

nmol/l

0.8

0.03

732

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

2.86

1.86

1.3

1.7

0.9

1.8

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

144

1.74

1.84

1.6

1.5

ug/l

0.5

0.4

0.32

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.21

1.84

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

175

1.66

1.82

1.2

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

108

1.85

1.81

1.5

1.6

ng/l

109.8

132.7

0.34

108

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

160

1.69

1.81

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.06

1.80

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

691

0.69

1.79

1.1

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

100

772

1.30

1.78

1.2

1.1

—

1.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

711

1.31

1.78

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

496

1.37

1.77

1.6

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

217

1829

1.19

1.75

2.5

2.0

g/l

38.8

37.9

2.03

180

1602

(3049242) von Willebrand panel - Platelet poor plasma

3.33

1.74

1.2

1.8

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.85

1.71

1.0

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

125

1.76

1.71

1.2

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

334

0.57

1.71

1.3

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

103

1311

0.78

1.71

1.3

1.4

—

(3048879) Bone marrow aspiration report

171

1.64

1.69

1.9

2.1

—

(3012441) Differential panel - Pleural fluid

587

0.68

1.67

1.8

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

580

1.33

1.65

3.3

3.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

318

1.45

1.63

1.5

1.8

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

130

1050

1.24

1.63

1.5

1.2

u/l

26.8

36.5

0.87

112

916

(3035947) Staphylolysin Ab [Units/volume] in Serum

278

1.48

1.60

1.1

iu/ml

3.8

3.6

—

(3045142) Bone marrow Pathology biopsy report

733

0.72

1.60

1.3

—

(40762814) Titanium [Mass/volume] in Blood

1.91

1.59

2.6

2.5

ug/l

2.6

4.4

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.00

1.58

1.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

313

1.44

1.56

1.5

iu/ml

4634153.9

1283335.4

—

(40768806) Pleura Pathology biopsy report

623

0.70

1.54

1.9

1.5

—

(4306422)

136

1113

1.23

1.53

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

105

1312

0.80

1.52

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

105

1311

0.80

1.52

1.3

1.4

—

(3045716) Anion gap in Serum or Plasma

274

1.46

1.51

4.0

2.2

mmol/l

9.0

9.3

—

209

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

234

2016

1.17

1.50

3.1

2.2

g/l

1.1

0.9

0.26

196

1756

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

417

1.37

1.50

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

289

2530

1.15

1.50

2.2

2.0

—

(1761868) Lipid panel - Serum or Plasma

2644

27402

0.95

1.48

3.2

2.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

496

1.33

1.47

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

638

1.29

1.43

3.7

5.1

u/ml

119.4

72.2

0.42

186

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.73

1.43

1.3

nmol/l

476.2

458.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.97

1.43

1.2

1.0

—

(3024263) Appearance of Synovial fluid

345

1.39

1.42

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1072

11394

0.93

1.38

2.7

3.1

mmol/l

2.4

1.64

935

10002

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

131

1082

1.21

1.38

1.1

iu/ml

119.9

9445.6

0.55

257

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

125

1028

1.22

1.37

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

174

1.55

1.36

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

608

0.72

1.36

1.6

1.5

e6/l

38191.0

61886.7

0.48

348

(3007463) Buprenorphine [Presence] in Urine

2.94

1.36

2.6

11.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

139

1157

1.20

1.36

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

209

1804

1.16

1.34

3.8

4.2

mmol/l

3.8

3.9

0.54

193

1708

(3020779) Urea [Moles/volume] in Serum or Plasma

613

5642

1.09

1.34

6.8

7.8

mmol/l

9.1

9.3

0.24

580

5398

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

332

1.39

1.34

1.2

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

167

1.56

1.34

1.5

1.1

—

(3020891) Body temperature

275

2423

1.14

1.33

4.9

4.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

754

7006

1.08

1.32

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

105

1.72

1.32

1.4

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

126

1042

1.21

1.32

1.8

1.7

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.81

1.31

2.4

2.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

683

0.75

1.30

1.6

1.5

e6/l

2201.8

2453.9

0.17

486

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

185

1.52

1.28

1.1

—

(3051651) Icteric interference index of Serum or Plasma

413

0.68

1.27

4.3

3.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

554

1.28

1.25

1.1

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

240

2106

1.14

1.25

3.8

4.0

mmol/l

1.5

1.4

0.61

233

2073

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

115

1387

0.83

1.25

3.4

3.6

u/ml

144.4

629.8

1.67

104

1268

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

191

2206

0.86

1.24

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

115

1.65

1.24

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.40

1.24

1.2

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

551

0.72

1.24

1.3

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

287

1.40

1.22

3.6

3.7

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.16

1.21

1.5

1.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

898

0.79

1.21

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

272

2416

1.13

1.19

2.4

3.7

u/ml

542.5

2537.2

0.99

221

2075

(3046861) Legionella sp Ag [Presence] in Urine

2.31

1.18

1.2

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

550

1.28

1.18

2.5

1.8

g/24h

0.5

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.70

1.17

1.7

—

(3045788) Cell count panel - Pleural fluid

533

0.73

1.17

1.7

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

322

0.65

1.16

1.6

1.9

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

437

1.31

1.16

1.0

ng/l

306.8

311.9

0.05

305

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

1.16

0.0

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

2.05

1.15

1.1

—

(4038314)

2.05

1.15

1.3

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

687

1.24

1.14

2.1

2.0

umol/l

6.7

7.4

0.09

497

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

724

6766

1.08

1.13

3.2

4.3

ug/l

16.9

28.7

0.58

567

5451

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

954

0.81

1.11

2.6

2.7

u/ml

97.9

1326.8

0.67

914

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

1.96

1.11

1.0

1.3

—

18.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.78

1.10

1.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.78

1.10

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

211

2394

0.88

1.10

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

221

1950

1.14

1.09

1.2

1.3

titre

75.5

147.6

1.31

186

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.38

1.09

1.4

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1049

0.82

1.08

1.7

1.8

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

845

7956

1.07

1.08

6.7

7.6

mmol/l

104.4

104.6

0.35

802

7806

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

329

1.34

1.08

1.2

1.1

u/l

11.7

22.3

3.72

254

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

330

1.34

1.06

1.2

1.1

u/l

76.8

80.8

0.24

260

(3034770) Mitochondria Ab [Titer] in Serum

218

1931

1.13

1.03

1.2

1.3

titre

991.3

918.9

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

437

1.28

1.03

1.0

ng/l

773.5

747.6

0.18

295

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

652

1.23

1.02

1.3

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

595

5545

1.08

1.02

6.6

7.6

mmol/l

1.3

0.03

577

5352

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

687

0.78

1.01

1.4

1.3

ug/l

5.7

4.2

0.33

586

(3048929) Epstein Barr virus Ab [Presence] in Serum

232

2069

1.12

0.99

1.3

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

426

0.73

0.99

1.1

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

440

1.27

0.99

1.0

ng/l

42.9

41.6

0.07

302

(3033799) Differential panel - Peritoneal fluid

225

0.62

0.99

1.4

1.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.71

0.98

1.0

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

163

1422

1.15

0.98

5.6

6.0

iu/ml

391.2

2819.7

1.14

199

(3009466) Valproate [Moles/volume] in Serum or Plasma

119

1014

1.18

0.97

4.1

5.4

umol/l

341.7

369.6

1.31

868

(3000012) Reticulocyte production index

327

1.32

0.97

1.4

1.5

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.96

0.0

1.3

—

29.4

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.96

0.0

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

284

1.34

0.96

2.6

3.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

153

1332

1.15

0.95

1.2

u/ml

244.1

279.5

0.95

101

864

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

786

1.20

0.95

1.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

199

1.41

0.95

1.3

1.5

ug/l

9.7

8.7

0.47

199

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

188

1662

1.13

0.94

2.7

2.1

g/l

0.0

0.50

171

1531

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

117

1.54

0.93

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

117

1.54

0.93

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

117

1.54

0.93

1.1

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

158

1.46

0.93

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

420

0.74

0.93

1.2

u/l

83.4

87.3

0.08

362

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

260

1.35

0.92

2.9

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

260

1.35

0.92

2.9

2.2

—

(3044009) aPTT.lupus sensitive (LA screen)

1.73

0.92

1.1

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

407

0.74

0.91

1.2

u/l

15.4

22.1

0.83

342

(3008536) Aspergillus sp Ab [Presence] in Serum

126

1.51

0.91

2.4

2.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.63

0.90

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.63

0.90

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

151

1.46

0.90

1.0

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.07

0.89

2.0

8.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

262

1.34

0.89

2.9

2.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

237

1.35

0.87

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

111

1.53

0.87

1.1

1.4

—

(44806420)

144

1.46

0.87

2.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

240

2167

1.11

0.86

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

213

1911

1.12

0.86

2.1

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

604

6419

0.94

0.85

2.5

u/l

32.0

41.1

2.11

504

5530

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

112

1.52

0.84

1.5

1.9

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.94

0.84

1.0

1.1

u/l

283.2

457.2

—

(3001556) Androgen free Index in Serum or Plasma

1.76

0.83

1.1

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

160

1416

1.13

0.82

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

106

911

1.17

0.82

1.0

u/ml

4.8

3.3

0.32

353

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

328

1.28

0.81

2.6

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

328

1.28

0.81

2.6

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

328

1.28

0.81

2.6

2.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

199

1786

1.12

0.81

2.6

2.1

g/l

0.0

0.16

182

1650

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.70

0.80

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

329

1.28

0.80

2.6

2.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

145

1279

1.14

0.79

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

145

1279

1.14

0.79

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

430

1.23

0.76

1.6

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

161

0.62

0.75

1.2

1.1

u/ml

57.3

61.1

—

153

(3009677) Dengue virus Ab [Presence] in Serum

2.08

0.74

1.0

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

109

948

1.15

0.74

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

423

1.23

0.74

1.0

u/ml

0.4

2.1

0.89

107

(40768446) Kidney Pathology biopsy report

289

0.73

1.3

1.6

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.80

0.72

6.1

5.4

—

(1002224) Polysomnography panel

310

3351

0.92

0.72

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

134

1.42

0.71

2.2

mmol/l

7.8

8.3

0.17

(3024932) HLA-DR beta [Type]

252

0.71

0.70

1.2

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

111

973

1.14

0.69

1.0

1.1

u/ml

3.8

3.6

0.05

369

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

204

1.32

0.68

1.1

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

275

1.27

0.68

1.2

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.63

0.66

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

127

1128

1.13

0.66

1.0

1.1

u/ml

2.4

1.8

0.16

265

(40765096) Chromosome analysis panel by Banding

190

0.68

0.65

1.5

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

117

1036

1.13

0.64

1.5

1.4

nmol/l

0.3

0.4

0.20

788

(3025130) Human papilloma virus identified in Specimen

912

0.86

0.62

1.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

230

2117

1.09

0.62

1.3

miu/ml

176.4

222.1

1.36

100

983

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.55

0.62

1.2

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.63

0.62

1.0

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.63

0.62

1.0

1.8

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.63

0.62

1.0

1.2

u/l

4.4

16.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.67

0.61

12.8

8.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

130

1.39

0.61

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

180

1640

1.10

0.61

2.8

2.1

g/l

0.0

0.00

167

1528

(40768443) Skin Pathology biopsy report

317

2959

1.07

0.61

1.2

—

(3042733) HLA Ab [Presence] in Serum

256

0.74

0.61

3.1

5.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

262

1.26

0.60

1.2

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

255

0.74

0.59

2.9

3.2

mg/l

7.5

7.8

0.07

211

(3024471) HLA-A [Type]

255

0.74

0.59

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

123

1101

1.12

0.58

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

345

1.22

0.58

1.2

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

147

1623

0.90

0.58

1.5

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

309

1.23

0.58

2.0

2.1

ug/min

97.3

206.1

0.67

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.48

0.57

1.2

1.3

nmol/l

0.5

0.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

392

1.20

0.56

1.6

1.5

mmol/l

8.3

7.9

0.33

243

(3022689) Creatine [Moles/volume] in Urine

195

0.72

0.56

1.3

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

148

1344

1.10

0.55

1.6

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

159

1.32

0.55

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.46

0.54

1.4

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.50

0.54

1.9

2.3

—

(3019174) dRVVT (LA screen)

1.50

0.54

1.0

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.48

0.53

1.0

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

349

1.20

0.53

1.4

1.6

mmol/24h

10.8

5.6

—

(4268621)

768

1.13

0.53

2.3

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.54

0.53

1.0

1.2

—

2.2

—

(3050794) Legionella sp Ab [Presence] in Serum

1.45

0.53

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

143

1301

1.10

0.52

1.4

1.5

u/ml

153.5

114.0

0.86

276

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

125

1130

1.11

0.52

1.3

1.2

u/ml

2.3

3.9

1.02

362

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

461

1.17

0.52

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

197

1822

1.08

0.51

2.6

3.0

mg/l

1.6

1.5

0.46

177

1688

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

462

1.17

0.51

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

121

1095

1.11

0.50

1.3

1.2

u/ml

3.7

4.2

0.21

481

(3001964) Herpes simplex virus Ag [Presence] in Specimen

180

1.28

0.49

1.4

1.6

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.52

0.48

1.1

1.0

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

775

1.12

0.48

1.7

2.2

33.1

32.9

0.13

769

(3018133) Calcium [Moles/volume] in Urine

1.40

0.48

1.7

2.0

mmol/l

3.3

2.7

0.41

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.47

0.47

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

118

1073

1.10

0.46

2.7

2.8

u/ml

329.5

2144.3

1.30

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.62

0.45

1.2

1.7

mg/l

2.1

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

394

1.17

0.44

1.3

1.2

—

(3024928) Oxygen saturation in Venous blood

146

1344

1.09

0.44

3.6

3.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

175

0.74

0.44

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.40

0.44

1.1

—

(3035880) pH of Pleural fluid

311

1.19

0.44

1.4

1.3

—

(3001729) Color of Synovial fluid

1.37

0.44

1.3

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

130

1.31

0.43

1.0

1.1

—

(3011648) Oxygen content in Venous blood

544

0.86

0.43

2.6

2.2

11.4

11.2

0.12

544

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.61

0.43

1.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

154

1425

1.08

0.42

1.4

u/ml

13.1

22.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

537

1.14

0.42

2.2

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

537

1.14

0.42

2.2

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

537

1.14

0.42

2.2

1.8

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

139

0.72

0.41

1.3

1.4

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.41

0.0

2.2

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.41

0.0

1.1

—

3302.5

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.40

0.0

6.2

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.40

0.0

1.0

—

12199.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

168

1.25

0.40

1.2

1.3

54.7

54.5

0.01

143

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

2.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

207

2204

0.94

0.40

1.6

2.1

96.2

91.8

2.24

192

2063

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.43

0.39

1.0

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.43

0.39

1.0

1.7

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.39

0.38

1.0

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.39

0.38

1.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

188

2004

0.94

0.38

2.0

2.6

g/l

3.5

3.6

0.25

174

1909

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

647

1.11

0.37

1.4

1.3

pmol/l

72.6

117.2

0.44

195

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.35

0.37

4.2

4.9

—

(40758558) Short blood count panel - Blood

1742

17110

1.02

0.37

5.8

7.1

—

(40758292) HTLV I+II Ab panel - Serum

125

1.28

0.36

1.3

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

244

1.19

0.36

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.27

0.36

1.0

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.40

0.35

1.0

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

222

0.81

0.34

2.8

1.9

e6/l

35261.3

16071.3

—

113

(40761995) Spermatozoa Progressive [#/volume] in Semen

167

0.78

0.34

4.5

3.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

776

1.10

0.34

1.6

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

209

1.20

0.33

3.2

3.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.32

0.33

1.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

192

2032

0.94

0.33

1.9

2.4

165.7

189.8

3.58

179

1932

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

166

0.78

0.33

9.1

5.9

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.68

0.33

2.5

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.68

0.33

1.3

1.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.28

0.32

1.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

602

0.90

0.32

1.0

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

465

1.12

0.31

1.6

1.4

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

801

1.09

0.30

3.1

3.4

nmol/l

3.3

12.5

0.74

784

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

352

3390

1.04

0.29

8.6

10.2

mmol/l

24.6

24.2

1.52

336

3191

(3009871) Measles virus Ab [Titer] in Serum

271

0.85

0.29

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

542

5263

1.03

0.29

1.3

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

185

1.19

0.29

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

285

2969

0.96

0.28

3.1

4.2

mmol/l

24.4

24.2

0.83

249

2692

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

345

1.13

0.28

1.4

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

753

0.92

0.28

1.3

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

384

0.88

0.26

1.0

u/ml

0.2

2.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

577

1.09

0.26

1.2

1.3

mmol/l

12.1

12.0

0.03

157

(3020650) Glucose [Presence] in Urine

207

1.16

0.25

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

154

1463

1.05

0.24

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.18

0.24

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

445

1.10

0.24

5.1

6.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

112

1189

0.94

0.24

1.4

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

899

1.07

0.24

1.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

411

3992

1.03

0.23

8.5

9.8

0.7

2.95

405

3966

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

786

0.93

0.23

2.5

2.4

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

412

4003

1.03

0.23

8.4

9.7

1.5

1.4

0.96

406

3979

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

172

1642

1.05

0.23

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

150

1427

1.05

0.23

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.28

0.23

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.28

0.23

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

188

1802

1.04

0.22

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.22

0.22

1.2

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.19

0.21

1.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.21

0.0

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

125.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

2.5

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.21

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

460

1.09

0.20

2.7

2.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

489

1.08

0.20

2.7

e6/l

678.6

702.7

0.09

201

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.22

0.20

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

112

0.80

0.20

1.9

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

490

0.92

0.20

1.2

1.1

—

(3022475) Manganese [Moles/volume] in Blood

1.20

0.19

1.2

1.3

—

(44806071)

1.22

0.19

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.15

0.19

1.0

—

14.3

—

(3052851) Hemolysis interference index of Serum or Plasma

199

1921

1.04

0.18

3.3

3.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

290

0.90

0.18

1.3

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

290

0.90

0.18

1.3

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

464

1.08

0.17

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

650

0.94

0.17

3.9

3.3

—

(3020393) Adenovirus Ag [Presence] in Stool

0.76

0.17

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.74

0.17

1.0

1.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.71

0.16

1.6

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

279

2716

1.03

0.16

1.7

mg/l

5.4

3.7

0.80

190

1878

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.13

0.16

1.3

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

225

1.11

0.16

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

119

0.84

0.15

2.4

2.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

419

1.07

0.15

1.0

u/ml

0.8

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.11

0.15

1.6

1.1

—

(21494434) Karyotype in Bone marrow

547

1.06

0.14

1.3

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

103

1.17

0.13

1.1

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

549

0.95

0.12

1.1

1.3

titre

62.0

224.3

—

106

(3036489) Thrombin time

264

2585

1.02

0.12

1.5

2.0

21.1

21.3

0.18

214

2251

(3044242) Glucose [Moles/volume] in Arterial blood

282

0.92

0.12

3.3

2.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

116

0.86

0.12

3.3

5.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

168

0.89

0.11

1.6

1.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

168

0.89

0.11

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.16

0.11

1.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

358

3523

1.02

0.10

2.3

3.6

u/ml

24.4

50.5

8.01

343

3404

(3026250) Tacrolimus [Mass/volume] in Blood

331

0.94

0.10

28.6

35.1

ug/l

8.1

7.3

1.52

303

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.15

0.09

2.1

2.2

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

145

0.90

0.09

1.1

1.2

116.3

105.7

0.81

137

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

1.04

0.09

1.2

1.6

pmol/l

15.4

21.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

625

0.96

0.09

1.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.13

0.09

1.0

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

136

1328

1.02

0.08

4.0

3.1

mg/l

30.8

27.1

0.42

820

(3003740) Influenza virus B Ag [Presence] in Specimen

119

1220

0.98

0.08

1.2

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

0.81

0.08

3.8

3.4

mg/l

1.1

1.0

—

(3017569) Oxygen content in Arterial blood

273

1.06

0.08

3.2

2.4

—

(3047189) Immunofixation for 24 hour Urine

287

0.94

0.08

2.3

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

137

1.10

0.07

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

817

1.03

0.07

1.0

u/ml

0.1

0.8

1.61

178

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.05

0.07

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

599

0.97

0.06

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

103

0.87

0.06

1.0

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

207

1.06

0.06

1.2

1.4

—

(3034426) Prothrombin time (PT)

272

0.96

0.04

1.4

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

140

1.07

0.04

1.1

1.5

—

(40768441) Liver Pathology biopsy report

524

0.97

0.04

1.3

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

221

0.95

0.04

1.3

2.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

705

0.98

0.04

1.2

u/l

47.9

62.7

2.03

472

(21494815) CD4 cells/100 lymphocytes in Specimen

594

0.98

0.04

2.1

2.3

37.2

41.7

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

513

0.97

0.04

1.4

umol/l

13.6

12.2

0.54

486

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

291

0.96

0.04

1.4

2.8

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

210

1.05

0.03

2.1

2.9

umol/l

27.2

29.3

0.38

143

(3002523) Influenza virus A Ag [Presence] in Specimen

120

1215

0.99

0.03

1.2

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

206

2076

0.99

0.03

3.0

3.2

u/ml

0.4

0.3

1.17

134

1167

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

271

1.03

0.02

2.8

2.2

—

(3044007) Cell count panel - Peritoneal fluid

202

1.04

0.02

3.1

2.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

133

1.05

0.01

2.5

2.9

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

247

0.97

0.01

1.9

1.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

247

0.97

0.01

2.5

2.1

e6/l

44365.6

838.5

0.75

168

(21494814) CD8 cells/100 lymphocytes in Specimen

273

1.03

0.01

1.6

2.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

463

1.02

0.01

1.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

294

1.02

0.00

1.2

6.2

mg/l

7176.1

896.9

0.41

207

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

424

1.01

0.00

1.4

1.6

u/l

3.2

4.7

0.59

213

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

266

1.02

0.00

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

115

0.96

0.00

1.1

—

(3000991) Gas panel - Venous blood

525

5255

1.00

0.00

7.6

9.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

570

5695

1.00

0.00

1.6

1.7

—

(3051101) Glucose [Moles/volume] in Cord blood

1.02

0.00

4.6

6.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

339

1.00

0.00

29.7

26.1

ug/l

115.7

116.4

0.02

277

(3041806) Other cells [#/volume] in Blood by Manual count

171

0.99

0.00

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.94

0.00

3.2

2.5

u/field

0.8

0.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.90

0.00

1.7

2.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.92

0.00

1.1

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

260

1.00

0.00

1.2

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.1

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

100

1.00

0.00

1.6

3.4

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(3007916) DNA double strand Ab [Titer] in Serum

0.95

0.00

1.6

1.5

—

291.7

—

(3017509) Phencyclidine [Presence] in Urine

0.99

0.00

1.0

1.7

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.88

0.00

1.2

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.0

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.0

—

10.7

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

0.92

0.00

1.3

2.1

umol/l

1.2

1.4

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_ROOTPLEXOTHUNS and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_ROOTPLEXOTHUNS	1.116 [1.01, 1.24]	0.034
Birth year	0.994 [0.99, 1.0]	0.182

During the follow-up period (1.1.1998 — 31.12.2019), 1878 out of 17306 females with G6_ROOTPLEXOTHUNS died.

Males

Parameter	HR [95% CI]	p-value
G6_ROOTPLEXOTHUNS	1.143 [1.03, 1.27]	0.011
Birth year	0.984 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 2262 out of 17987 males with G6_ROOTPLEXOTHUNS died.

Mortality risk

Mortality risk for people of age

years, who have G6_ROOTPLEXOTHUNS.

N-year risk	Females	Males
1	0.09%	0.202%
5	0.549%	1.193%
10	1.621%	2.904%
15	3.157%	5.689%
20	5.518%	9.527%

Relationships between endpoints

↥

Index endpoint: G6_ROOTPLEXOTHUNS – Other and unspecified nerve root and plexus disorders, also in other diseases

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other and unspecified nerve root and plexus disorders, also in other diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints